Valdecoxib
Valdecoxib Brand names, Valdecoxib Analogs
Valdecoxib Brand Names Mixture
- No information avaliable
Valdecoxib Chemical_Formula
Valdecoxib RX_link
Valdecoxib fda sheet
Valdecoxib msds (material safety sheet)
Valdecoxib Synthesis Reference
Valdecoxib Molecular Weight
Valdecoxib Melting Point
Valdecoxib H2O Solubility
Valdecoxib State
Valdecoxib LogP
Valdecoxib Dosage Forms
Valdecoxib Indication
Valdecoxib Pharmacology
Valdecoxib Absorption
Valdecoxib side effects and Toxicity
Valdecoxib Patient Information
BEXTRA can cause GI discomfort and, rarely, more serious GI side effects, which may result in hospitalization and even fatal outcomes. Although serious GI tract ulcerations and bleeding can occur without warning symptoms, patients should be alert for the signs and symptoms of ulcerations and bleeding, and should ask for medical advice when observing any indicative sign or symptoms. Patients should be apprised of the importance of this follow-up Effects ó Risk of GI Ulceration, Bleeding, and Perforation).
Patients should report to their physicians, signs or symptoms of gastrointestinal ulceration or bleeding, skin rash, weight gain, or edema.
Patients should be informed of the warning signs and symptoms of hepatotoxicity (e.g., nausea, fatigue, lethargy, pruritus, jaundice, right upper quadrant tenderness, and flu-like symptoms). If these occur, patients should be instructed to stop therapy and seek immediate medical attention.
Patients should also be instructed to seek immediate emergency help in the case of an anaphylactoid reaction.
In late pregnancy, BEXTRA should be avoided because it may cause premature closure of the ductus arteriosus.
